S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
Log in
NASDAQ:LQDA

Liquidia Technologies Stock Forecast, Price & News

$2.79
-0.24 (-7.92 %)
(As of 11/30/2020 05:00 PM ET)
Add
Compare
Today's Range
$2.75
Now: $2.79
$3.20
50-Day Range
$2.86
MA: $4.00
$5.79
52-Week Range
$2.65
Now: $2.79
$12.10
Volume1.61 million shs
Average Volume448,516 shs
Market Capitalization$105.33 million
P/E RatioN/A
Dividend YieldN/A
Beta0.51
Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.
Liquidia Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.46 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LQDA
CUSIPN/A
CIKN/A
Phone(919) 328-4400
Employees64

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.07 million
Book Value$1.24 per share

Profitability

Net Income$-47,580,000.00

Miscellaneous

Market Cap$105.33 million
Next Earnings Date3/10/2021 (Estimated)
OptionableNot Optionable
$2.79
-0.24 (-7.92 %)
(As of 11/30/2020 05:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LQDA News and Ratings via Email

Sign-up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Liquidia Technologies (NASDAQ:LQDA) Frequently Asked Questions

How has Liquidia Technologies' stock been impacted by Coronavirus?

Liquidia Technologies' stock was trading at $3.66 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LQDA shares have decreased by 23.8% and is now trading at $2.79.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Liquidia Technologies?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Liquidia Technologies in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Liquidia Technologies
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Liquidia Technologies?

Wall Street analysts have given Liquidia Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Liquidia Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Liquidia Technologies' next earnings date?

Liquidia Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021.
View our earnings forecast for Liquidia Technologies
.

How were Liquidia Technologies' earnings last quarter?

Liquidia Technologies, Inc. (NASDAQ:LQDA) announced its quarterly earnings data on Thursday, November, 12th. The company reported ($0.40) earnings per share for the quarter, missing analysts' consensus estimates of ($0.37) by $0.03.
View Liquidia Technologies' earnings history
.

What price target have analysts set for LQDA?

3 analysts have issued twelve-month price targets for Liquidia Technologies' stock. Their forecasts range from $4.00 to $40.00. On average, they anticipate Liquidia Technologies' stock price to reach $22.67 in the next year. This suggests a possible upside of 712.4% from the stock's current price.
View analysts' price targets for Liquidia Technologies
.

Are investors shorting Liquidia Technologies?

Liquidia Technologies saw a decrease in short interest during the month of October. As of October 15th, there was short interest totaling 1,720,000 shares, a decrease of 13.1% from the September 30th total of 1,980,000 shares. Based on an average daily trading volume, of 590,700 shares, the short-interest ratio is currently 2.9 days.
View Liquidia Technologies' Short Interest
.

Who are some of Liquidia Technologies' key competitors?

What other stocks do shareholders of Liquidia Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Liquidia Technologies investors own include VBI Vaccines (VBIV), OPKO Health (OPK), Aldeyra Therapeutics (ALDX), Sorrento Therapeutics (SRNE), vTv Therapeutics (VTVT), Genocea Biosciences (GNCA), Inovio Pharmaceuticals (INO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA) and NVIDIA (NVDA).

Who are Liquidia Technologies' key executives?

Liquidia Technologies' management team includes the following people:
  • Neal F. Fowler, Chief Executive Officer & Director
  • Robert A. Lippe, Chief Operations Officer
  • Steven Bariahtaris, Chief Financial Officer
  • Benjamin Maynor, Senior Vice President-Research & Development
  • Tushar Shah, Chief Medical Officer

When did Liquidia Technologies IPO?

(LQDA) raised $50 million in an initial public offering on Thursday, July 26th 2018. The company issued 4,500,000 shares at $10.00-$12.00 per share. Jefferies and Cowen served as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers.

What is Liquidia Technologies' stock symbol?

Liquidia Technologies trades on the NASDAQ under the ticker symbol "LQDA."

Who are Liquidia Technologies' major shareholders?

Liquidia Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include ArrowMark Colorado Holdings LLC (5.02%), BlackRock Inc. (3.83%), Great Point Partners LLC (3.15%), Sofinnova Investments Inc. (1.80%), State Street Corp (0.87%) and Keel Point LLC (0.35%). Company insiders that own Liquidia Technologies stock include Benjamin Maynor, Eshelman Ventures, Llc, Kevin K Gordon and Timothy Albury.
View institutional ownership trends for Liquidia Technologies
.

Which institutional investors are selling Liquidia Technologies stock?

LQDA stock was sold by a variety of institutional investors in the last quarter, including Sofinnova Investments Inc., Great Point Partners LLC, ArrowMark Colorado Holdings LLC, and JPMorgan Chase & Co..
View insider buying and selling activity for Liquidia Technologies
.

Which institutional investors are buying Liquidia Technologies stock?

LQDA stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Keel Point LLC, Morgan Stanley, Squarepoint Ops LLC, AQR Capital Management LLC, Sigma Planning Corp, State Street Corp, and Charles Schwab Investment Management Inc..
View insider buying and selling activity for Liquidia Technologies
.

How do I buy shares of Liquidia Technologies?

Shares of LQDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Liquidia Technologies' stock price today?

One share of LQDA stock can currently be purchased for approximately $2.79.

How big of a company is Liquidia Technologies?

Liquidia Technologies has a market capitalization of $105.33 million and generates $8.07 million in revenue each year. The company earns $-47,580,000.00 in net income (profit) each year or ($2.59) on an earnings per share basis. Liquidia Technologies employs 64 workers across the globe.

What is Liquidia Technologies' official website?

The official website for Liquidia Technologies is www.liquidia.com.

How can I contact Liquidia Technologies?

Liquidia Technologies' mailing address is 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 328-4400 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.